CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Esperion Therapeutics, Inc. Company Snapshot
Esperion Therapeutics, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Esperion Therapeutics with three other companies in this sector in UNITED STATES : Clovis Oncology Inc (2019 sales of $143.01 million of which 100% was Anti Cancer Medicines), Xencor Inc ($156.70 million of which 72% was Licensing), and Heron Therapeutics Inc ($145.97 million of which 100% was Polymer Technologies).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Esperion Therapeutics, Inc.
  Stock Performance Chart for Esperion Therapeutics, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 37.52
(Figures in U.S. Dollars)
1 Week -4.3%   13 Weeks 15.5%  
4 Weeks -18.3%   52 Weeks -0.7%  
 
Esperion Therapeutics, Inc. Key Data:
  Ticker: ESPR Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 148,364,000
(Year Ending Jan 2020).
Employees: 193
  Currency: U.S. Dollars Market Cap: 1,041,242,096
  Fiscal Yr Ends: December Shares Outstanding: 27,751,655
  Share Type: Common Closely Held Shares: 272,553
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.